Cite
HARVARD Citation
Scott, S. et al. (2019). Assessment of plasma cell myeloma minimal residual disease testing by flow cytometry in an international inter‐laboratory study: Is it ready for primetime use?. Cytometry. 96 (3), pp. 201-208. [Online].